| Literature DB >> 26780512 |
Shira Knafo1,2,3, Cristina Sánchez-Puelles1, Ernest Palomer1, Igotz Delgado2, Jonathan E Draffin1, Janire Mingo4, Tina Wahle5,6, Kanwardeep Kaleka7, Liping Mou8, Inmaculada Pereda-Perez9, Edvin Klosi10, Erik B Faber10, Heidi M Chapman10, Laura Lozano-Montes1, Ana Ortega-Molina11, Lara Ordóñez-Gutiérrez1,12, Francisco Wandosell1,12, Jose Viña13, Carlos G Dotti1, Randy A Hall8, Rafael Pulido3,4, Nashaat Z Gerges7, Andrew M Chan14, Mark R Spaller10, Manuel Serrano11, César Venero9, José A Esteban1.
Abstract
Dyshomeostasis of amyloid-β peptide (Aβ) is responsible for synaptic malfunctions leading to cognitive deficits ranging from mild impairment to full-blown dementia in Alzheimer's disease. Aβ appears to skew synaptic plasticity events toward depression. We found that inhibition of PTEN, a lipid phosphatase that is essential to long-term depression, rescued normal synaptic function and cognition in cellular and animal models of Alzheimer's disease. Conversely, transgenic mice that overexpressed PTEN displayed synaptic depression that mimicked and occluded Aβ-induced depression. Mechanistically, Aβ triggers a PDZ-dependent recruitment of PTEN into the postsynaptic compartment. Using a PTEN knock-in mouse lacking the PDZ motif, and a cell-permeable interfering peptide, we found that this mechanism is crucial for Aβ-induced synaptic toxicity and cognitive dysfunction. Our results provide fundamental information on the molecular mechanisms of Aβ-induced synaptic malfunction and may offer new mechanism-based therapeutic targets to counteract downstream Aβ signaling.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26780512 DOI: 10.1038/nn.4225
Source DB: PubMed Journal: Nat Neurosci ISSN: 1097-6256 Impact factor: 24.884